- |||||||||| dexamethasone injection / Generic mfg.
Trial primary completion date: Use of Dexamethasone in Uterine Artery Embolization (clinicaltrials.gov) - Apr 14, 2015 P=N/A, N=64, Recruiting, Trial primary completion date: Feb 2015 --> Aug 2015 Trial primary completion date: Dec 2014 --> Apr 2015
- |||||||||| topotecan / Generic mfg., carboplatin / Generic mfg., cyclophosphamide / Generic mfg.
Trial primary completion date: Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer (clinicaltrials.gov) - Apr 14, 2015 P1, N=48, Active, not recruiting, Trial primary completion date: May 2015 --> May 2016 Trial primary completion date: Jun 2014 --> Dec 2015
- |||||||||| Trial primary completion date: Perceptions of Cervical Cancer Among Asian Americans (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=60, Active, not recruiting, Trial primary completion date: Apr 2014 --> Apr 2015 Trial primary completion date: Dec 2015 --> Dec 2016
- |||||||||| Enrollment change, Trial withdrawal, Trial primary completion date: High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection (clinicaltrials.gov) - Apr 14, 2015
P2, N=0, Withdrawn, Trial primary completion date: Dec 2015 --> Dec 2016 N=20 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Aug 2018 --> Mar 2015
- |||||||||| TheraCIM (nimotuzumab) / Daiichi Sankyo, Oncoscience, Biocon
Trial completion, Trial initiation date, Metastases: A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer (clinicaltrials.gov) - Apr 14, 2015 P1/2, N=15, Completed, Initiation date: Nov 2014 --> Aug 2015 | Trial primary completion date: Sep 2015 --> Jun 2016 Active, not recruiting --> Completed | Initiation date: Jan 2009 --> Jul 2008
- |||||||||| Enrollment open, Trial initiation date, Trial primary completion date: Clinical Utility of Rapid CT/NG Testing in the ED (clinicaltrials.gov) - Apr 13, 2015
P=N/A, N=300, Recruiting, Recruiting --> Completed | N=20 --> 32 | Trial primary completion date: Dec 2013 --> Mar 2014 Not yet recruiting --> Recruiting | Initiation date: Dec 2014 --> Apr 2015 | Trial primary completion date: Apr 2015 --> Apr 2016
- |||||||||| metformin / Generic mfg.
Trial completion: Metformin and Oral Contraceptives in PCOS (clinicaltrials.gov) - Apr 13, 2015 P4, N=90, Completed, Active, not recruiting --> Completed Recruiting --> Completed
- |||||||||| Trial completion: A Two-Phase Clinical Study of the Minerva AURORA Ablation System (clinicaltrials.gov) - Apr 9, 2015
P=N/A, N=23, Completed, Not yet recruiting --> Active, not recruiting | Initiation date: Jul 2012 --> Dec 2012 | Trial primary completion date: Aug 2013 --> Apr 2014 Active, not recruiting --> Completed
- |||||||||| desogestrel / Generic mfg.
Trial completion, Trial primary completion date, Surgery: Postoperative Desogestrel for Endometriosis Related Pain (clinicaltrials.gov) - Apr 9, 2015 P=N/A, N=40, Completed, Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Oct 2014
- |||||||||| Trial completion, Trial primary completion date, Surgery: Dilators for Dyspareunia Prevention (clinicaltrials.gov) - Apr 9, 2015
P4, N=60, Completed, Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Oct 2014 Active, not recruiting --> Completed | Trial primary completion date: Sep 2012 --> Aug 2013
- |||||||||| Enrollment change, Trial withdrawal, Trial primary completion date: Vulvar Contact Dermatitis Resulting From Urine Incontinence (clinicaltrials.gov) - Apr 8, 2015
P=N/A, N=0, Withdrawn, Active, not recruiting --> Completed | Trial primary completion date: Sep 2012 --> Aug 2013 N=400 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Mar 2013 --> Mar 2012
- |||||||||| Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion, Trial initiation date, Trial primary completion date: Bone Marrow Stem Cell Treatment for Asherman's Syndrome and Endometrial Atrophy (clinicaltrials.gov) - Apr 8, 2015 P4, N=16, Completed, Not yet recruiting --> Recruiting Recruiting --> Completed | Initiation date: May 2014 --> Apr 2013 | Trial primary completion date: Jan 2015 --> Sep 2014
- |||||||||| Trial completion, Trial primary completion date: Postpartum Dyspareunia Resulting From Vaginal Atrophy (clinicaltrials.gov) - Apr 8, 2015
P=N/A, N=117, Completed, Recruiting --> Completed | N=150 --> 195 Recruiting --> Completed | Trial primary completion date: Mar 2013 --> Sep 2013
- |||||||||| letrozole / Generic mfg.
Trial completion, Phase classification, Trial primary completion date, IO biomarker: Letrozole as a Treatment of Endometrial Cancer (clinicaltrials.gov) - Apr 6, 2015 P=N/A, N=43, Completed, Active, not recruiting --> Completed | N=500 --> 175 Recruiting --> Completed | Phase classification: P3 --> PN/A | Trial primary completion date: Aug 2012 --> Sep 2013
- |||||||||| Arenegyr (NGR-hTNF) / AGC Biologics
Enrollment closed, Trial primary completion date, Combination therapy: Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer (clinicaltrials.gov) - Apr 6, 2015 P2, N=124, Active, not recruiting, Recruiting --> Completed | Phase classification: P3 --> PN/A | Trial primary completion date: Aug 2012 --> Sep 2013 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Jun 2016
- |||||||||| fenofibrate / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome (clinicaltrials.gov) - Apr 3, 2015 P=N/A, N=4, Terminated, Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Jun 2016 N=12 --> 4 | Recruiting --> Terminated | Trial primary completion date: Oct 2011 --> Feb 2015; Poor recruitment
- |||||||||| cabergoline / Generic mfg.
Enrollment closed, Trial primary completion date: Cabergoline and Coasting to Prevent OHSS (clinicaltrials.gov) - Apr 3, 2015 P3, N=300, Active, not recruiting, N=12 --> 4 | Recruiting --> Terminated | Trial primary completion date: Oct 2011 --> Feb 2015; Poor recruitment Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Jul 2015
|